Cambridge, UK: Cambridge Epigenetix (CEGX) and NuGEN Technologies, leaders in innovative epigenetic technologies, today announced that they have entered into a partnership agreement to integrate the CEGX TrueMethyl technology for oxidative bisulfite sequencing (oxBS-Seq) with NuGEN’s innovative NGS library preparation kits. The signing of the agreement will enable CEGX to focus on its epigenetic biomarker discovery programmes, both in-house and […]
New technology shifts safety paradigm from responding to food contamination to prevention. SALT LAKE CITY, UT – CibusDx, Inc. announced today that it has acquired Pronucleotein Biotechnologies, San Antonio, TX and licensed ApolloDx’s revolutionary diagnostic platform for development and commercialization of a new food safety testing system that can be used at any point in […]
BMG LABTECH reports successful development of new technology within the MetaCell-TM project Ortenberg, Germany – BMG LABTECH developed a new gas ramping function that can fully manipulate the environment within a microplate reader, by mimicking in vitro hypoxia and ischaemia/reperfusion. Equipped with this unique feature, the CLARIOstar® with Atmopheric Control Unit (ACU) is the first plate reader that is able to […]
The agreement is to explore a next generation gene and cell therapy manufacturing platform for clinical and commercial applications London, UK: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, has announced it has agreed, as lead partner, to enter into a collaboration agreement with a consortium of partners, […]
On the heels of opening Advanced Analytical SARL in France last year, AATI is thrilled to announce the opening of our third international office. Located approximately 40 miles northwest of London in Milton Keynes, England, the AATI UK office will provide direct sales and support to the entire United Kingdom. With the opening of the […]
IPSWICH, MA, USA — The Wellcome Trust Sanger Institute is one of the world’s leading genome centers, and through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research […]
Acquisition broadens BioreclamationIVT’s disease-state biospecimen capabilities, particularly in oncology, and expands its scientific service offerings for diagnostic and drug development researchers Westbury, NY – BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has acquired Asterand Bioscience™, a global provider of high quality, well-characterized human tissue and research solutions with a focus […]
Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Madison, WI BellBrook Labs announces the launch of their latest drug discovery tool, the AptaFluor SAH […]
The latest version of eve® can integrate with a wide range of third-party bioreactors and equipment from a number of different suppliers, e.g. Sartorius DCU, Applikon or Matlab. The process data is handled by a single, integrated solution, making the eve® bioprocess platform software a truly universal choice for bioprocess projects. Bottmingen — eve® offers […]
Vienna, Austria – Today Lexogen, the transcriptomics and next-generation sequencing company, has launched a Small RNA-Seq Library Prep Kit, and in doing so closed the gap in their portfolio of RNA sample preparation protocols. Ever since small RNA (sRNA) was found to play key functional roles in the regulation of gene expression, researchers have taken […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
